Banks Benefit From ...
Health Care: Drugs
Icagen Inc. (ICGN: NASDAQ)
$5.99 0.00 | 0.00%
10/27/11 - 03:59 PM ET
9.87K / 73.20K
Vol / Avg. Vol:5.99 / 5.99
Open / Prev. Close:5.99 - 6.00
Today's Range:1.03 - 8.40
52 Wk Range:238.42%
Performance YTD:TheStreet Rating:
Portfolios with ICGN
- Portfolio NameUser Type
- UserPART 7 JPMorgan 28th Annual...
- ContributorBarron's Activist Stocks 9-...
- UserLast Day of the JPMorgan He...
- UserFirst One by JiMi G
- UserPART 7 JPMorgan 26th Annual...
- UserSpec #1
- Userbaileyman2003 Portfolio 1
- Userbminato Portfolio 1
- Userdecaking
- UserBetty McAlpin Portfolio 1
Latest ICGN Headlines from TheStreet
- Icagen Stock Falls On Unusually High Volume (ICGN) 07.19.11 | 04:07 pm
- Icagen, MannKind: After-Hours Trading 06.24.11 | 07:06 pm
- Icagen CEO Discusses Q4 2010 Results - Earnings Call Transcript 03.19.11 | 11:03 pm
- Icagen Reports Fourth Quarter And Full Year 2010 Financial Results And Operational Highlights 03.07.11 | 08:03 am
- Icagen To Announce Fourth Quarter And Full Year 2010 Results And Conduct Conference Call On March 7, 2011 02.23.11 | 08:02 am
- Icagen To Present At The 13th Annual BIO CEO & Investor Conference On February 15, 2011 02.03.11 | 08:02 am
- Icagen Announces Lifting Of Clinical Hold Of ICA-105665 02.02.11 | 08:02 am
- Icagen Announces Management Changes 12.20.10 | 04:12 pm
- Icagen And Pfizer Initiate Phase I Trial In Nav1.7 Program 12.20.10 | 08:12 am
- Icagen And Pfizer Select Compound For Advancement In Nav1.7 Program 11.30.10 | 08:11 am
Press Releases for ICGN
- Pfizer Announces Expiration Of Subsequent Offering Period And Completion Of Tender Offer For Shares Of Icagen, Inc. - Business Wire 09.20.11 | 08:09 am
- Pfizer Extends Subsequent Offering Period Of Tender Offer To Acquire Icagen, Inc. - Business Wire 09.13.11 | 08:09 am
- Pfizer Announces Successful Completion Of Initial Cash Tender Offer For Outstanding Shares Of Icagen, Inc. And Commencement Of Subsequent Offering Period - Business Wire 09.06.11 | 08:09 am
- Pfizer Extends Tender Offer To Acquire Icagen, Inc. - Business Wire 09.02.11 | 08:09 am
- Merlin Nexus And New Leaf Venture Partners Comment On Extension Of Tender Offer Deadline In Conjunction With Pfizer's Proposed $56 Million Acquisition Of Icagen - PR Newswire 09.01.11 | 10:09 am
- Pfizer Extends Tender Offer To Acquire Icagen, Inc. - Business Wire 09.01.11 | 08:09 am
- Merlin Nexus And New Leaf Venture Partners Continue To Contest Proposed $56 Million Acquisition Of Icagen By Pfizer - PR Newswire 08.25.11 | 08:08 am
- Bull & Lifshitz, LLP Announces Investigation Of Icagen, Inc. - Business Wire 07.21.11 | 04:07 pm
- Ryan & Maniskas, LLP Announces Investigation Of Icagen, Inc. - Business Wire 07.21.11 | 10:07 am
- Murray Frank LLP Investigates Icagen, Inc. - Business Wire 07.20.11 | 10:07 pm
Partner Headlines for ICGN
- Pfizer Extends Icagen Tender Offer - Analyst Blog - Zacks 09.02.11 | 05:09 pm
- Mid-Day Update: Stocks Off Session Lows After Initial Plunge; Government Employment Report Weighs - NASDAQ 09.02.11 | 04:09 pm
- US Indexes Sharply Lower at Session's Half on Dismal Employment Report; Commodities Mixed - NASDAQ 09.02.11 | 04:09 pm
- Mid-Day Update: US Indexes Near Flatline; Manufacturing Data Provides Early Support to Stocks - NASDAQ 09.01.11 | 04:09 pm
- Stocks Flat as Investors Eye Government Employment Data Due Tomorrow; Commodities Mixed - NASDAQ 09.01.11 | 04:09 pm
- Mid-Day Update: Stocks Firm at Session's Half; Personal Incomes Data Tops Expectations - NASDAQ 08.29.11 | 04:08 pm
- US Indexes Firm at Session's Half; Commodities Mixed as Gold Slips - NASDAQ 08.29.11 | 04:08 pm
- Unemployment Data Weighs on Stocks; Gold Retrenches as Commodities Slip - NASDAQ 08.25.11 | 04:08 pm
- Mid-Day Update: Stock Slide Continues; Unemployment Claims Weigh on Sentiment - NASDAQ 08.25.11 | 04:08 pm
- Stocks Struggle Amid European Worries, Weak Housing Report; Commodities Mixed - NASDAQ 08.16.11 | 04:08 pm
